SV

Sarita Vyas

Active Director Director DIN 06741702
DIN 06741702 First appointment Sep 2012 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2012
Shareholding value •••• Premium profile

About Sarita Vyas

Data last updated:

Sarita Vyas is a Director at Rashmi Drug House Private Limited (since 2012). The company operates in Chemicals. Rashmi Drug House Private Limited reported revenue of ₹4.7 Lakh (FY 2025).

DIN 06741702
Primary Designation Director
Industry Chemicals
First Appointment 12 Sep 2012
Oldest Company Age 35 yrs
Largest company Rashmi Drug House Private Limited · ₹4.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rashmi Drug House Private Limited U26943RJ1991PTC005926
Director12 Sep 20121991₹4.7 Lakh (FY 2025)Active

Board colleagues of Sarita Vyas

NameDINCompanyDesignation
Deen Dayal Vyas01522541Rashmi Drug House Private LimitedDirector

Directorship timeline

Open interactive timeline →
Rashmi Drug House Private Limited
Premium access

Shareholding and investment profile for Sarita Vyas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sarita Vyas

Sarita Vyas currently holds 1 directorship: Rashmi Drug House Private Limited (Director, since 12 Sep 2012, revenue ₹4.7 Lakh (FY 2025)).

Sarita Vyas was first appointed on 12 Sep 2012 as Director at Rashmi Drug House Private Limited.

The current boards of Sarita Vyas's companies include Deen Dayal Vyas (Rashmi Drug House Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available